Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.57 |
| ▸ | SCN1A | P35498 | 1/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.38 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7198607 | 0.84 | MTNR1A (0.53) | MTNR1ASCN1ASCN2ASCN3AALOX5 | |
| SCHEMBL7203987 | 0.80 | MTNR1A (0.53) | MTNR1ASCN1ASCN2ASCN3AALOX5 | |
| SCHEMBL7202222 | 0.80 | MTNR1A (0.57) | MTNR1ASCN1ASCN2ASCN3AALOX5 | |
| SCHEMBL17002620 | 0.77 | MTNR1A (0.53) | MTNR1ASCN1ASCN2ASCN3AAHR | |
| SCHEMBL7204577 | 0.75 | MTNR1A (0.51) | MTNR1ASCN1ASCN2ASCN3AAHR | |
| SCHEMBL7203114 | 0.75 | MTNR1A (0.47) | MTNR1ASCN1ASCN2ASCN3AAHR | |
| SCHEMBL7200454 | 0.73 | MTNR1A (0.47) | MTNR1A | |
| SCHEMBL7203743 | 0.73 | MTNR1A (1.00) | MTNR1ASCN1ASCN2ASCN3A | |
| SCHEMBL10862979 | 0.73 | MTNR1A (0.50) | MTNR1ASCN1ASCN2ASCN3A | |
| SCHEMBL10861440 | 0.71 | MTNR1A (0.48) | MTNR1ASCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1489077-A1 | 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2004-12-22 | — | — | EP | disclosed |